Chester, United Kingdom

Alison E Bretnall


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):

Title: The Innovative Journey of Alison E. Bretnall

Introduction

Alison E. Bretnall, an accomplished inventor based in Chester, GB, has made significant contributions to the field of diabetes treatment. Holding one patent, her work has the potential to impact the lives of many people managing diabetes.

Latest Patents

Alison's notable patent, titled "Salts of Metformin and Method," focuses on novel salts of the antidiabetic agent metformin. This patent introduces metformin salts formed with dibasic acids in a 2:1 molar ratio, specifically highlighting metformin (2:1) fumarate and metformin (2:1) succinate. These innovative salts can be employed alone or in conjunction with other antihyperglycemic agents like glyburide for the treatment of diabetes. Furthermore, the patent outlines methods for utilizing these novel metformin salts to treat diabetes effectively.

Career Highlights

Alison is currently affiliated with Bristol-Myers Squibb Company, where she plays a pivotal role in research and development. Her commitment to advancing diabetes treatments through innovative pharmaceutical solutions makes her a noteworthy figure in her field.

Collaborations

Throughout her career, Alison has collaborated with several talented professionals, including her coworkers Peter Timmins and William J. Winter. These collaborations have enriched her work and contributed to the development of groundbreaking solutions in diabetes management.

Conclusion

Alison E. Bretnall's innovative approach to addressing diabetes through her patent on metformin salts showcases her dedication to improving patient outcomes. As a valued member of the team at Bristol-Myers Squibb Company, her contributions continue to pave the way for advancements in antidiabetic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…